FDA approval Cyclosporine - Gengraf clinical trails
Home       Treatment        Side Effects       Pari       FDA Aproval

 

FDA approval for Cyclosporine - Gengraf, Neoral

Cyclosporine is an effective drug that controls the action of the immune system. It is used for many other problems like rejecting a kidney, liver or heart transplant. It was approved for the patients undergoing transplants of the organs in the year 1983. The magazine NPF is working on this drug more on the brand Neoral and publishes its articles. The neoral brand of cyclosporine is used in the treatment of arthritis and also severe psoriasis. But this drug is not approved by the Food and Drug Administration for such purposes.

Still the drug is used in the purposes like pancreatic, corneal, bone marrow and transplants such as that of liver, heart and drug. The other non approved treatment of this drug are alopecia areata, aplasticanemia, atopic dermatitis, Behcets disease, biliary cirrhosis, Chrons disease, ulcerative colitis, diabetes, lichen planus, lupus nephritis, multiple sclerosis, myasthenia gravis and other diseases. There are many other purposes for which this drug is used other than what is mentioned here. Many of these have still not attained the FDA approval.

The manufacturing of this drug produce the drug in various forms like the capsules, tablets and pills.Gengraf oral solution of 100 mg/ml, oral capsule of 100mg and 25 mg, Neoral oral liquid of 100 mg, oral solution 100 mg/ml are all approved by the FDA in US. Clinical trails and researches carried out in the labs have proved Cyclosporine to be a well proved drug from the category it belongs. This assures the high rate of sale of this drug and its bright future in the years to come withy increase in rate of transplants taking place in the present time.
 

Home       Treatment        Side Effects       Pari       FDA Aproval